NLRP3 and viral infectious disease: Investigations into these inhibitors have revealed their capacity to modulate the NLRP3 pathway, effectively attenuating the exaggerated inflammatory response prompted by viral infection, thereby curtailing tissue damage, and fostering improved patient prognoses.